MLTX Stock Analysis: Buy, Sell, or Hold?
MLTX - MoonLake Immunotherapeutics Class A Ordinary Shares
$18.24
-0.17 (-0.92%)
▼
5d:
+6.05%
30d:
+1.22%
90d:
+16.85%
BUY
HIGH Confidence
Analysis Updated: May 13, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Smart Money Distribution
MLTX is up 3.5% this week, but smart money is buying puts. Top strike: $15 2026-06-18 with 21 OI. Put ratio: 100% View Scanner →
Strength: 6.8/10
Get Alerted When MLTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
36 traders called MLTX this week
91% bullish • 7 bearish
91% bullish • 7 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MLTX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: MLTX shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: MLTX is currently trading at $18.24, which is considered slightly high relative to its 30-day fair value range of $16.76 to $18.36.
Technical Outlook: Technically, MLTX is in a uptrend. Immediate support is located at $16.06, while resistance sits at $21.00.
Market Sentiment: MLTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.77 (+45.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MLTX is in a uptrend. Immediate support is located at $16.06, while resistance sits at $21.00.
Market Sentiment: MLTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.77 (+45.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$16.76 -
$18.36
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 45.4% below Wall St target ($26.77)
Trading Range Analysis
30-Day Trading Range
$16.76 -
$18.36
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$16.06
Resistance Level
$21.00
Current Trend
Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.05
Wall Street Target
$26.77
(+45.4%)
Share & Embed Analysis
Last updated: May 14, 2026 12:45 PM ET
Data refreshes hourly during market hours. Next update: 1:45 PM
Data refreshes hourly during market hours. Next update: 1:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MLTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Da Silva Jorge Santos
SELL
51873 shares
2026-04-13
Da Silva Jorge Santos
SELL
98127 shares
2026-04-10
Bvf Partners L P/Il
SELL
3750000 shares
2026-03-31
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 60 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$104 | 59 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 56 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$127 | 59 HOLD |
Advanced MLTX Option Strategies
Professional options setups generated by AI based on today's MLTX price and gamma walls.
